5
Deciphering the Function of Selected Novel Streptococcus pneumoniae Proteins in Pathogenesis and Development of Target Derived Antagonists Yaffa Mizrachi Nebenzahl 1,2 Understanding the sequential molecular interactions of S. pneumoniae with its human host may lead to the identification of molecules crucial for disease development. We have previously identified proteins in the cell-wall with known enzymatic activities in the cytoplasm Fructose bisphosphate aldolase (FBA), Phosphoenolpyruvate protein phosphotransferase (PtsA), Glutamyl tRNA synthetase (GtS), NADH oxidase (NOX), Aspartate Carbamoyltransferase catalytic subunit (ATCase), PTS system, mannose-specific IIAB components (PTS MAN ) and ABC transporter substrate-binding protein (ABC) We hypothesized that some of these proteins in the cell-wall may function as adhesins

Deciphering the Function of Selected Novel Streptococcus pneumoniae Proteins in Pathogenesis and Development of Target Derived Antagonists Yaffa Mizrachi

Embed Size (px)

Citation preview

Page 1: Deciphering the Function of Selected Novel Streptococcus pneumoniae Proteins in Pathogenesis and Development of Target Derived Antagonists Yaffa Mizrachi

Deciphering the Function of Selected Novel Streptococcus pneumoniae Proteins in Pathogenesis and Development of

Target Derived AntagonistsYaffa Mizrachi Nebenzahl1,2

Understanding the sequential molecular interactions of S. pneumoniae with its human host may lead to the identification of molecules crucial for disease development. We have previously identified proteins in the cell-wall with known enzymatic activities in the cytoplasm

Fructose bisphosphate aldolase (FBA), Phosphoenolpyruvate protein phosphotransferase (PtsA), Glutamyl tRNA synthetase (GtS), NADH oxidase (NOX), Aspartate Carbamoyltransferase catalytic subunit (ATCase), PTS system, mannose-specific IIAB components (PTSMAN) and ABC transporter substrate-binding protein (ABC)

Bioinformatic analysis demonstrated that these proteins are conserved among the sequenced strains of S. pneumoniae

We hypothesized that some of these proteins in the cell-wall may function as adhesins

Page 2: Deciphering the Function of Selected Novel Streptococcus pneumoniae Proteins in Pathogenesis and Development of Target Derived Antagonists Yaffa Mizrachi

rPtsA rPtsA

A549

A549

A549

Inserted peptides were sequencedand aligned against the human genome

Inhibition of adhesion to A549

Peptide synthesis from the human

homology regionA549

Inhibition of adhesion

In vitro

In vivoInhibition of colonization

Identification of Putative receptors to bacterial adhesins

Page 3: Deciphering the Function of Selected Novel Streptococcus pneumoniae Proteins in Pathogenesis and Development of Target Derived Antagonists Yaffa Mizrachi

Target molecules in the Host A549 cells

Page 4: Deciphering the Function of Selected Novel Streptococcus pneumoniae Proteins in Pathogenesis and Development of Target Derived Antagonists Yaffa Mizrachi

Target molecules in the Host U251 cells

Page 5: Deciphering the Function of Selected Novel Streptococcus pneumoniae Proteins in Pathogenesis and Development of Target Derived Antagonists Yaffa Mizrachi

Summary• A group of S. pneumoniae cell-wall proteins were identified and found

to function as putative adhesins• Null mutant bacteria lacking those proteins were found to have reduced

adhesion in vitro and reduced virulence in vivo in the mouse models• Screening a combinatorial peptide library expressed in filamentous

phages identified protein binding peptides • Sequences homologous to these peptides were identified in cell

membrane and ECM proteins • Peptides derived from the human membrane and extracellular matrix

proteins, homologous to the insert peptides in the inhibitory phages, were found to – Inhibit bacterial adhesion to the lung derived A549 cells– Reduce bacterial load in the nasopharynx and the lung in intranasal

inoculation model and mortality in IN and the intraperitoneal inoculation mouse model

• Five out of the six proteins suspected to be the adhesin’s putative targets molecules in the host were found to be expressed in the A549 cells and 4 were found in U251 cells

• These peptides may be considered for future treatment of S. pneumoniae clinical infections